Allergy & Clinical Immunology Perspective and Journal Articles

 
 

  • Medscape Physician Assistant Burnout Report 2022 PAs share their experiences with burnout and depression and whether it's spurred thoughts of leaving the profession.
  • Vedolizumab in Elderly and Nonelderly IBD Patients Is vedolizumab a safe and effective treatment option for both elderly and younger IBD patients?
  • ESMO's New Focus on Cancer Prevention WebMD's Chief Medical Officer, John Whyte, talks with ESMO Co-chair Fabrice André on the organization's focus on cancer prevention and recent advances in cancer screening and treatment.
  • A Virus Poised to Jump Species to Humans   Researchers show how close we are to another pandemic, and how it will start with zoonotic transmission.
  • Episode 4: Team Effort: Multidisciplinary Approach to Severe Asthma   Drs Wechsler and Jackson discuss their partnerships with nurses, asthma educators, psychologists, speech therapists, and other specialists when diagnosing and treating patients with severe asthma.
  • The Dubious Value of Online Reviews Neurologist Allan Block describes online reviews of doctors by patients as "the wild west," with minimal rules and little if any oversight ― and argues that both good and bad ratings "mean nothing."
  • Atopic Dermatitis Highlights From EADV 2022   Highlights in atopic dermatitis from EADV include efficacy of dupilumab in clinical practice, JAK inhibitors upadacitinib and baricitinib, and a 28-country assessment of AD burden of disease.
  • Pulmonary Rehabilitation for COPD in a Low Resource Setting Could this program help COPD patients access pulmonary rehabilitation services in areas with limited resources?
  • Medscape RN/LPN Compensation Report 2022 Nurses from the largest nursing specialties share their views in a new report on nurse income, including bonus pay, education, and certifications.
  • Airborne Anaphylaxis: Highlighting an Invisible Enemy Although rare, anaphylactic reactions to airborne allergens do occur and can be potentially deadly. Learn about the potential causes and how to recognize this disorder.
  • LAMA Takes a Hit in New Update We've heard this story before; LAMA monotherapy is the latest casualty of current asthma treatment.
  • The Bionic Pancreas Triumphs in Pivotal Trial   We are closer than ever to a truly hands-free closed-loop insulin delivery system for type 1 diabetes.
  • Substance and Opioid Abuse Report 2022 Physicians reveal their attitudes about substance abuse and how those challenges affect themselves and their patient's lives.
  • Severe Outcomes Among Immunocompromised Adults With COVID-19 This study found that immunocompromised patients accounted for over 12% of all adult COVID-19 hospitalizations and had increased odds of ICU admission and death, irrespective of vaccination status.
  • An Update on JAK Inhibitors in Skin Disease This paper summarizes recent trials of JAK inhibitors tested in patients with moderate to severe atopic dermatitis, including topical RUX, oral abrocitinib, upadacitinib, and baricitinib.
  • No Such Thing as an Easy Fix Neurologist Allan Block notes that although it's common for people to look for shortcuts, there's no easy fix when it comes to research — and life in general.
  • An Unusual Presentation of Anaphylaxis With Severe Hypertension Anaphylaxis is usually associated with low blood pressure, but this unusual case highlights the need to be aware that it may present with elevated BP as well.
  • Infographic: Incomes Climb for Young Physicians For physicians younger than 40 years, average compensation rose in 2021 at rates even faster than for their older peers. However, a pay gap persists between younger male and female doctors.
  • Young Physicians Compensation Report 2022 Medscape's Young Physician Compensation Report 2022 explores changes in overall income, incentives, and attitudes about work amid recovery from a very tough year.
  • The Best Reason to Get an Omicron Booster   Perry Wilson is getting an Omicron booster, but his reason for doing so might not be what you think it is.